Spectronics Corporation (Spectronics) appeals the judgment of the United States District Court for the Eastern District of New York dismissing its action under the Declaratory Judgment Act, 28 U.S.C. § 2201 (1988), against H.B. Fuller Company, Inc., and H.B. Fuller Automotive Products, Inc., (collectively Fuller), for lack of an actual controversy. We affirm.
I
Spectronics manufactures and sells DY-GLO-12, a fluorescent leak detection additive used in automotive air conditioning systems. United States Patent No. 4,758,-366 (the ’366 patent), assigned to Fuller, claims certain fluorescent dyes used to detect leaks in air conditioning and refrigeration systems. Fuller sent letters to the industry in 1988 announcing the addition of the ’366 patent to its growing family of patents and its developing “patent strategy” with respect to its tracer dye line of products. The letters did not refer to Spec-tronics’ DYGLO-12 or any other competing products. Spectronics filed suit alleging that “an actual controversy exists” as to *633 whether it was infringing the ’366 patent claims, and that the purpose of Fuller’s letters to the industry “was to intimidate both [Spectronics] and [Spectronics’] customers in that anyone making, using or selling ‘DYGLO-12’ would be liable for such activities under [the ’366 patent].”
In its complaint, Spectronics asserted three causes of action: (1) entitlement to a declaratory judgment of invalidity or non-infringement of the claims of the ’366 patent under the Declaratory Judgment Act, 28 U.S.C. § 2201 (1988); (2) federal antitrust violations under the Sherman Act, 15 U.S.C. § 2 (1988); and (3) tortious interference with business relations. Before filing its answer, Fuller moved to dismiss all three counts under Fed.R.Civ.P. 12. Fuller’s motion was granted in part insofar as the parties stipulated to dismissal without prejudice of the antitrust and tortious interference counts, leaving at issue only the declaratory judgment count. Fuller then answered, filing a contingent counterclaim of patent infringement, and thereafter filed a second motion to dismiss the declaratory judgment action for lack of an actual controversy. During a hearing on that motion, Fuller presented the District Court with a declaration that the ’366 patent had been submitted to the Patent and Trademark Office (PTO) for reissue. The District Court denied the second motion.
Eight days later, Fuller filed in the District Court a covenant not to sue Spectron-ics for infringement of the ’366 patent claims. The covenant, styled a “Statement of Non Liability,” provides:
Defendant, H.B. Fuller Company, Inc., has filed a reissue application to reissue U.S. Patent No. 4,758,366 cancelling claims 1-18 and seeking new claims.
Spectronics has no liability to Defendants or any successors-in-interest to U.S. Patent No. 4,758,366 for infringement of claims 1-18 of U.S. Patent No. 4,758,366, and Defendants and any successors-in-interest to U.S. Patent No. 4,758,366 will not sue Spectronics for infringement of claims 1-18 of U.S. Patent No. 4,758,366.
Fuller filed a third motion to dismiss for lack of an actual controversy, which was granted in a memorandum opinion and order that incorporated “the [District] Court’s extensive discussions with counsel on the record at oral argument on August 17, 1990,” as permitted by Fed.R.Civ.P. 52(a). Spectronics Corp v. H.B. Fuller Co., CY 88-3803, slip op. at 1 (E.D.N.Y. Aug. 17, 1990) (incorporated oral argument and colloquy hereinafter cited as “Hearing Transcript”). In granting the third motion to dismiss, the District Court explained that:
[although this Court found on two previous occasions that a case or controversy existed in that plaintiff had shown the existence of facts underlying a “reasonable apprehension” that it would be sued for infringement of [the ’366 patent claims], defendants’ June 5, 1990 filing with the Patent and Trademark Office of a Reissue Application for this patent, taken in concert with its June 15, 1990, filing with this Court of a “Statement of Non-Liability,” operate to divest this Court of jurisdiction over this matter. Although plaintiff Spectronics Corporation may be charged with infringement of the claims that may result from the reissue application, plaintiff cannot, on the record before this Court, demonstrate an objectively reasonable apprehension that it will face an infringement suit on the ’366 patent.
The Declaratory Judgment Act provides, in pertinent part:
In a case of actual controversy within its jurisdiction, ... any court of the United States, upon the filing of an appropriate pleading, may declare the rights and other legal relations of any interested party seeking such declaration, whether or not further relief is or could be sought.
28 U.S.C. § 2201(a) (1988) (emphasis added).
The existence of an actual controversy is an absolute predicate for declara
*634
tory judgment jurisdiction.
Grain Processing Corp. v. American Maize-Products Co.,
Spectronics disputes none of the facts in the record, but argues the legal proposition that those facts established an actual controversy under the patent laws. In these circumstances, we review dismissal as a matter of law, keeping in mind that the District Court’s “view of the legal effect of the fact pattern before it is not to be lightly disregarded.”
Arrowhead,
The long established rule of law is that a declaratory judgment plaintiff must establish an actual controversy on the “totality of the circumstances.”
Maryland Casualty Co. v. Pacific Coal & Oil Co.,
On appeal, Spectronics assigns error to the District Court’s conclusion that Spec-tronics did not demonstrate an objectively reasonable apprehension of suit, asserting first that such apprehension should be measured at the time of filing of its complaint, and second, that the potential grant of a reissue patent manifestly places Spectron-ics at risk of further litigation on the subject matter contained in the specification of the ’366 patent.
Ill
We first address the contention that dismissal was improper because declaratory judgment jurisdiction must be determined solely on the facts as they existed at the time the complaint was filed. Spectronics relies on
Arrowhead,
We agree wholeheartedly that in person-am and subject matter jurisdictional facts must be pleaded, and proved when challenged, and that later events may not create jurisdiction where none existed at the time of filing. Thus, well-pleaded jurisdictional facts, such as diversity of citizenship, cannot be ousted by subsequent events.
Mollan v. Torrance,
“Article III of the Constitution requires that there be a live case or controversy at the time that a federal court decides the case.”
Amstar Corp. v. Envirotech Corp.,
Mootness is “one of the doctrines that clusters about Article III, to define further the case-or-controversy requirement that limits the federal judicial power in our system of government.”
McKinney v. U.S. Dep’t of Treasury,
The exercise of judicial power under Article III depends at all times on the existence of a case or controversy. The burden is on Spectronics “to establish that jurisdiction over its declaratory judgment action existed at,
and has continued since,
the time the complaint was filed.”
International Medical, 787
F.2d at 575,
IV
We must therefore consider whether the District Court was wrong in concluding that post-filing events rendered moot the controversy in the instant action. Neither party disputes that, under ordinary circumstances, Spectronics’ production of DYGLO-12 would potentially infringe the claims of the ’366 patent. However, with admirable candor, counsel for Spectronics stated his opinion that in view of the statement of non liability, the ’366 patent claims could never be enforced against Spectronics. Hearing Transcript at 11-12. We agree that, in view of the statement of non liability, Fuller is forever estopped from asserting the '366 patent claims against Spectronics. Having requested a declaration of non-infringement of the ’366 patent claims, Spectronics for all practical purposes has won the case pleaded in its complaint.
Spectronics contends, however, that the potential grant of a reissue patent manifestly places it at risk of further litigation on the subject matter contained in the specification of the ’366 patent, which Spectron-ics believes will reappear in the claims of the reissue patent and form the basis for threatened or actual litigation against it. Spectronics refers us to a letter it received from Fuller’s counsel, which accompanied the statement of non liability. That letter reiterated that “Fuller has clearly and unequivocally stated that there is no liability by Spectronics for infringement of the claims that are presently in the patent,” but also indicated that “[i]f new claims emerge from the reissue [proceeding], and if there is an issue of infringement by Spectronics, and if there is subsequent litigation,” Spectronics would be free to raise a specified defense. Thus, argues Spec-tronics, while the reissue application is pending before the PTO, “the ’366 patent is merely in limbo, and may be resurrected at some future time, albeit in reduced form.”
There is, however, no guarantee that the reissue patent will eventually issue. 37 C.F.R. § 1.178 (1990) (“[i]f a reissue be refused, the original patent will be returned to applicant upon his request”);
see State Indus., Inc. v. A.O. Smith Corp.,
There are sensible reasons why the existence of issued patent claims, presently enforceable against Spectronics, are a requisite to litigation of a declaratory judgment action. The claims of the patent are the subject matter of the suit; they are sought to be declared invalid or non-infringed. The allegedly infringing product is to be measured against the claims set forth in the patent.
Jervis B. Webb Co.,
*637
Before issuance, what the scope of claims will be “is something totally unforeseeable.”
State Indus.,
THE COURT: So what you’re saying ... is that there will come a day almost assuredly as — what’s the expression— God makes green apples, or something like that — that we will be fighting over a patent and the series of claims. What those claims are, however, we don’t yet know, do we?
COUNSEL FOR SPECTRONICS: That is correct.
THE COURT: We have a pretty good idea but we don’t know the precise dimension of what this controversy will eventually evolve into. Correct?
COUNSEL FOR SPECTRONICS: That is correct.
Hearing Transcript at 15.
Spectronics also contends that the reissue application supports jurisdiction because any claims that reissue will be “a vestige of” the ’366 patent claims. Under 35 U.S.C. § 252 (1988)
3
and our case law, when original claims are reissued without substantive change, they are generally enforceable from the date the original patent was granted.
Kaufman Co. v. Lantech Inc.,
Beneath Spectronics’ contention appears to lie the argument that it could be held liable for its current allegedly infringing activity if any of the reissue claims are “identical” to the original claims within the meaning of § 252. However, § 252 also provides that identical reissue claims “shall constitute a continuation” of the original claims, and that surrender of the original claims upon reissuance of identical claims “shall not affect any action then pending nor abate any cause of action then existing.” In the instant case, Fuller asserted in the statement of non liability that Spec-tronics “has no liability to [Fuller] for infringement of claims 1-18 of [the ’366 patent],” and unequivocally reiterated in its letter accompanying the statement that “there is no liability by Spectronics for infringement” of those claims. In addition, Fuller “released Spectronics from any liability with respect to the claims of the ’366 patent. This includes past products, current products or products contemplated in the future. Because Spectronics has been absolved from liability on all the claims of the ’366 patent, there will be no future confrontation with respect to them.” Brief for Appellees at 28, Spectronics Corp. v. H.B. Fuller Co., No. 91-1041 (Fed.Cir. filed Feb. 7, 1991).
Although Spectronics may have some cause to fear a suit for future infringement of substantively non-identical claims after *638 reissue, it has no cause for concern that it can be held liable for practicing the invention claimed in the ’366 patent. As to that invention, Fuller is estopped by its statement of non liability, on its face and as explained by Fuller, from asserting liability for the making, selling or using of any Speetronics’ product that would infringe the claims of the ’366 patent.
V
In sum, the District Court did not err in concluding that post-filing events rendered moot the controversy in this case. To proceed would “involve the court in rendering a forbidden advisory opinion.”
Arrowhead,
Having duly considered and rejected Speetronics’ other arguments on appeal, we affirm the judgment of the District Court granting Fuller’s motion to dismiss for lack of jurisdiction.
AFFIRMED.
Notes
.
See also International Medical,
.
See also Jervis B. Webb Co. v. Southern Sys., Inc.,
. Section 252 provides, in pertinent part:
The surrender of the original patent shall take effect upon the issue of the reissued patent, and every reissued patent shall have the same effect and operation in law, on the trial of actions for causes thereafter arising, as if the same had been originally granted in such amended form, but in so far as the claims of the original and reissued patents are identical, such surrender shall not affect any action then pending nor abate any cause of action then existing, and the reissued patent, to the extent that its claims are identical with the original patent, shall constitute a continuation thereof and have effect continuously from the date of the original patent.
No reissued patent shall abridge or affect the right of any person or his successors in business who made, purchased or used prior to the grant of a reissue anything patented by the reissued patent, to continue the use of, or to sell to others to be used or sold, the specific thing so made, purchased or used, unless the making, using or selling of such thing infringes a valid claim of the reissued patent which was in the original patent.
